Report adverse events

Healthcare providers are asked to report any suspected adverse reactions. Reporting forms and information can be found at*. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.

In addition you can use the ViiV online reporting form. As this facility is provided under our service agreement with GlaxoSmithKline (GSK), please choose the relevant ViiV Healthcare medicine from the drop-down product list on the form.

If the suspected adverse event involves a pregnancy exposure, please consider enrolling your patient on the Antiretroviral Pregnancy Registry*. This is a voluntary prospective, exposure-registration, observational study designed to collect and evaluate data on the outcomes of pregnancy exposures to antiretroviral products. It is intended to provide an early signal of any major teratogenic effect associated with a prenatal exposure to the products monitored through the Registry. Healthcare providers are asked to prospectively (before outcome of pregnancy is known) register women who have been exposed during pregnancy to the medications followed in the Registry. Patient confidentiality is strictly guarded, with no identifying patient information collected.

* ViiV Healthcare does not recommend, endorse or accept liability for sites controlled by third parties.